Dysregulation of proliferative pathways, such as MAPK, NF-kappa B signalling pathway PI3K-AKT, and JAK-STAT signalling, emphasises the central role of uncontrolled cell proliferation and survival in AML development [83,84]. This evidence concerns the gene AKT1 and acute myeloid leukemia.